Webster Bank, N. A. Abb Vie Inc. Transaction History

Webster Bank, N. A.

$932 Million
Q3 2024

A detailed history of Webster Bank, N. A. transactions in Abb Vie Inc. stock. As of the latest transaction made, Webster Bank, N. A. holds 63,001 shares of ABBV stock, worth $11.3 Million. This represents 1.34% of its overall portfolio holdings.

Number of Shares

63,001

Previous 65,463 3.76%

Holding current value

$11.3 Million

Previous $11.2 Million 10.8%

% of portfolio

1.34%

Previous 1.24%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$163.84 - $199.33 $403,374 - $490,750	-2,462 Reduced 3.76%	63,001 $12.4 Million
Q2 2024 Jul 12, 2024	SELL	$154.79 - $180.76 $300,756 - $351,216	-1,943 Reduced 2.88%	65,463 $11.2 Million
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $27,968 - $31,867	-175 Reduced 0.26%	67,406 $12.3 Million
Q4 2023 Jan 23, 2024	BUY	$137.6 - $154.97 $53,113 - $59,818	386 Added 0.57%	67,581 $10.5 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $350,673 - $405,956	-2,625 Reduced 3.76%	67,195 $10 Million
Q2 2023 Jul 13, 2023	SELL	$132.51 - $164.9 $220,894 - $274,888	-1,667 Reduced 2.33%	69,820 $9.41 Million
Q1 2023 Apr 13, 2023	SELL	$144.61 - $166.54 $214,022 - $246,479	-1,480 Reduced 2.03%	71,487 $11.4 Million
Q4 2022 Jan 18, 2023	SELL	$138.31 - $165.87 $78,560 - $94,214	-568 Reduced 0.77%	72,967 $11.8 Million
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $32,210 - $36,943	240 Added 0.33%	73,535 $9.87 Million
Q2 2022 Jul 12, 2022	SELL	$137.62 - $174.96 $111,885 - $142,242	-813 Reduced 1.1%	73,295 $11.2 Million
Q1 2022 Apr 13, 2022	BUY	$131.98 - $163.75 $128,944 - $159,983	977 Added 1.34%	74,108 $12 Million
Q4 2021 Jan 12, 2022	SELL	$107.43 - $135.93 $39,534 - $50,022	-368 Reduced 0.5%	73,131 $9.9 Million
Q3 2021 Oct 12, 2021	BUY	$106.4 - $120.78 $2.19 Million - $2.49 Million	20,589 Added 38.91%	73,499 $7.93 Million
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $1.45 Million - $1.62 Million	-13,793 Reduced 20.68%	52,910 $5.96 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $101,072 - $111,268	988 Added 1.5%	66,703 $7.22 Million
Q4 2020 Jan 07, 2021	BUY	$80.49 - $108.67 $423,296 - $571,495	5,259 Added 8.7%	65,715 $7.04 Million
Q3 2020 Oct 22, 2020	BUY	$85.91 - $100.83 $615,459 - $722,346	7,164 Added 13.44%	60,456 $5.3 Million
Q2 2020 Jul 09, 2020	BUY	$73.37 - $98.18 $214,240 - $286,685	2,920 Added 5.8%	53,292 $5.23 Million
Q1 2020 Apr 21, 2020	SELL	$64.5 - $97.79 $1.43 Million - $2.17 Million	-22,183 Reduced 30.57%	50,372 $3.84 Million
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $1.52 Million - $1.9 Million	21,087 Added 40.97%	72,555 $6.42 Million
Q3 2019 Oct 02, 2019	BUY	$62.98 - $75.72 $54,225 - $65,194	861 Added 1.7%	51,468 $3.9 Million
Q2 2019 Jul 11, 2019	SELL	$65.7 - $83.98 $30,156 - $38,546	-459 Reduced 0.9%	50,607 $3.68 Million
Q1 2019 Apr 10, 2019	BUY	$77.14 - $90.79 $73,591 - $86,613	954 Added 1.9%	51,066 $4.12 Million
Q4 2018 Jan 09, 2019	SELL	$77.85 - $96.01 $16,659 - $20,546	-214 Reduced 0.43%	50,112 $4.62 Million
Q3 2018 Oct 12, 2018	SELL	$88.91 - $98.84 $63,303 - $70,374	-712 Reduced 1.4%	50,326 $4.76 Million
Q2 2018 Jul 12, 2018	SELL	$89.78 - $106.23 $56,561 - $66,924	-630 Reduced 1.22%	51,038 $4.73 Million
Q1 2018 Apr 19, 2018	BUY	$92.01 - $123.21 $111,608 - $149,453	1,213 Added 2.4%	51,668 $4.89 Million
Q4 2017 Jan 23, 2018	SELL	$89.56 - $98.21 $123,055 - $134,940	-1,374 Reduced 2.65%	50,455 $4.88 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $3.62 Million - $4.62 Million	51,829	51,829 $4.61 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Webster Bank, N. A., based on Form 13F filings with the SEC.

News

Stay updated on Webster Bank, N. A. with notifications on news.

Account